THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $108,370 | -2.8% | 9,988 | +0.6% | 0.01% | 0.0% |
| Q4 2022 | $111,437 | -20.4% | 9,932 | -28.5% | 0.01% | -27.3% |
| Q3 2022 | $140,000 | +125.8% | 13,900 | +101.3% | 0.01% | +83.3% |
| Q2 2022 | $62,000 | -37.4% | 6,905 | +3.1% | 0.01% | -45.5% |
| Q3 2020 | $99,000 | -62.2% | 6,700 | -33.9% | 0.01% | -57.7% |
| Q4 2019 | $262,000 | +329.5% | 10,141 | +221.9% | 0.03% | +333.3% |
| Q3 2019 | $61,000 | -50.8% | 3,150 | -58.6% | 0.01% | -50.0% |
| Q2 2019 | $124,000 | +1277.8% | 7,600 | +1749.1% | 0.01% | +1100.0% |
| Q1 2018 | $9,000 | – | 411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |